Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

Balance Sheet

Inspect the capital base behind the business.

Assets

$139.99M

FY 2025 · Annual

-6.4% YoY

Liabilities

$298.95M

FY 2025 · Annual

+5.7% YoY

Equity

-$158.95M

FY 2025 · Annual

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$133.0M
Short-term Investments$117.1M
Receivables$20.3M
Inventory$45.4M
Other Current$15.6M
Total Current Assets$331.4M
PP&E (Net)$49.2M
Intangible Assets$1.6M
Long-term Investments$6.3M
Other Non-current$2.6M
Total Non-current Assets$59.6M
Total Assets$391.0M

Analysis

Selected assets total $391.0M for Latest. The largest visible component is Cash & Equivalents at $133.0M, about 34.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 5, 2026
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipNov 3, 2026
8-KCurrent reportNov 3, 2026

How much cash does ALMR have?

Alamar Biosciences, Inc. (ALMR) reported $30.00M in cash and equivalents in fiscal 2025.

How much debt does ALMR carry?

Alamar Biosciences, Inc. (ALMR) reported $41.47M of total debt, with net debt of $11.47M.